SE441751B - Forfarande for framstellning av nya rifamyciner - Google Patents
Forfarande for framstellning av nya rifamycinerInfo
- Publication number
- SE441751B SE441751B SE7805863A SE7805863A SE441751B SE 441751 B SE441751 B SE 441751B SE 7805863 A SE7805863 A SE 7805863A SE 7805863 A SE7805863 A SE 7805863A SE 441751 B SE441751 B SE 441751B
- Authority
- SE
- Sweden
- Prior art keywords
- formula
- rifamycin
- preparation
- new
- rifamycines
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 claims description 7
- HJYYPODYNSCCOU-ODRIEIDWSA-N rifamycin SV Chemical class OC1=C(C(O)=C2C)C3=C(O)C=C1NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O HJYYPODYNSCCOU-ODRIEIDWSA-N 0.000 claims description 7
- 125000004432 carbon atom Chemical group C* 0.000 claims description 6
- 125000000217 alkyl group Chemical group 0.000 claims description 3
- 229910052799 carbon Inorganic materials 0.000 claims 1
- XUWHAWMETYGRKB-UHFFFAOYSA-N piperidin-2-one Chemical compound O=C1CCCCN1 XUWHAWMETYGRKB-UHFFFAOYSA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- 125000001495 ethyl group Chemical class [H]C([H])([H])C([H])([H])* 0.000 description 6
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 5
- QBRFPWPICDILII-WVKYYCEASA-N 3-amino-4-iminorifamycin-s Chemical compound O=C1C(C(O)=C2C)=C3C(N)=C(N)C1=NC(=O)\C(C)=C/C=C/[C@H](C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@H](OC(C)=O)[C@H](C)[C@@H](OC)\C=C\O[C@@]1(C)OC2=C3C1=O QBRFPWPICDILII-WVKYYCEASA-N 0.000 description 4
- VRJHQPZVIGNGMX-UHFFFAOYSA-N 4-piperidinone Chemical class O=C1CCNCC1 VRJHQPZVIGNGMX-UHFFFAOYSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- -1 4-substituted-piperidones Chemical class 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000012074 organic phase Substances 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 125000003542 3-methylbutan-2-yl group Chemical group [H]C([H])([H])C([H])(*)C([H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 2
- 239000005695 Ammonium acetate Substances 0.000 description 2
- 229930189077 Rifamycin Natural products 0.000 description 2
- 229940043376 ammonium acetate Drugs 0.000 description 2
- 235000019257 ammonium acetate Nutrition 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 2
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 2
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 2
- 229960003292 rifamycin Drugs 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- OCNWYKFGWLGNHZ-UHFFFAOYSA-N 1-butylpiperidin-4-one Chemical compound CCCCN1CCC(=O)CC1 OCNWYKFGWLGNHZ-UHFFFAOYSA-N 0.000 description 1
- BDVKAMAALQXGLM-UHFFFAOYSA-N 1-ethylpiperidin-4-one Chemical compound CCN1CCC(=O)CC1 BDVKAMAALQXGLM-UHFFFAOYSA-N 0.000 description 1
- NUWRORAIHKGQGZ-UHFFFAOYSA-N 1-pentan-3-ylpiperidin-4-one Chemical compound CCC(CC)N1CCC(=O)CC1 NUWRORAIHKGQGZ-UHFFFAOYSA-N 0.000 description 1
- GTEUDVZENMLOPB-UHFFFAOYSA-N 1-pentylpiperidin-4-one Chemical compound CCCCCN1CCC(=O)CC1 GTEUDVZENMLOPB-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241001646725 Mycobacterium tuberculosis H37Rv Species 0.000 description 1
- 108700035964 Mycobacterium tuberculosis HsaD Proteins 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 231100000517 death Toxicity 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Communicable Diseases (AREA)
- Veterinary Medicine (AREA)
- Oncology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pulmonology (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE2825445A DE2825445C2 (de) | 1975-06-13 | 1978-06-09 | Rifamycin-S-Verbindungen und Verfahren zu ihrer Herstellung |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7805863L SE7805863L (sv) | 1979-11-24 |
| SE441751B true SE441751B (sv) | 1985-11-04 |
Family
ID=6041475
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7805863A SE441751B (sv) | 1978-06-09 | 1978-05-23 | Forfarande for framstellning av nya rifamyciner |
Country Status (8)
| Country | Link |
|---|---|
| JP (1) | JPS557203A (enrdf_load_html_response) |
| BE (1) | BE870570R (enrdf_load_html_response) |
| CA (1) | CA1089453A (enrdf_load_html_response) |
| CH (1) | CH633014A5 (enrdf_load_html_response) |
| FR (1) | FR2426690A2 (enrdf_load_html_response) |
| GB (1) | GB1603127A (enrdf_load_html_response) |
| NL (2) | NL182564C (enrdf_load_html_response) |
| SE (1) | SE441751B (enrdf_load_html_response) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (it) * | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
| WO2008008480A2 (en) * | 2006-07-12 | 2008-01-17 | Cumbre Pharmaceuticals Inc. | Nitroheteroaryl-containing rifamycin derivatives |
| US7884099B2 (en) | 2007-11-16 | 2011-02-08 | Cumbre Ip Ventures, L.P. | Quinolone carboxylic acid-substituted rifamycin derivatives |
| RU2496475C2 (ru) | 2011-10-26 | 2013-10-27 | Александр Васильевич Иващенко | Фармацевтическая композиция и набор для лечения бактериальных инфекций |
| CN103408571B (zh) * | 2013-08-23 | 2015-11-18 | 成都樵枫科技发展有限公司 | 利福布丁的晶型i及其制备方法和用途 |
| CN106279205B (zh) * | 2015-05-12 | 2020-07-21 | 重庆华邦胜凯制药有限公司 | 制备利福霉素s衍生物的方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1056271B (it) * | 1975-05-20 | 1982-01-30 | Archifar Ind Chim Trentino | Prodotti derivati dalle amine aromatiche |
| DK345977A (da) * | 1976-09-30 | 1978-03-31 | Archifar Ind Chim Trentino | G rifamycinforbindelser og fremgangsmaade til deres fremstillin |
-
1978
- 1978-05-22 CH CH554478A patent/CH633014A5/it not_active IP Right Cessation
- 1978-05-23 SE SE7805863A patent/SE441751B/sv not_active IP Right Cessation
- 1978-05-24 GB GB22170/78A patent/GB1603127A/en not_active Expired
- 1978-05-24 FR FR7815450A patent/FR2426690A2/fr active Granted
- 1978-05-30 CA CA304,380A patent/CA1089453A/en not_active Expired
- 1978-06-20 NL NLAANVRAGE7806659,A patent/NL182564C/xx not_active IP Right Cessation
- 1978-06-27 JP JP7706378A patent/JPS557203A/ja active Granted
- 1978-09-18 BE BE190561A patent/BE870570R/xx active
-
1995
- 1995-11-22 NL NL950028C patent/NL950028I2/nl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1089453A (en) | 1980-11-11 |
| BE870570R (fr) | 1979-01-15 |
| NL182564C (nl) | 1988-04-05 |
| JPH0114238B2 (enrdf_load_html_response) | 1989-03-10 |
| NL182564B (nl) | 1987-11-02 |
| SE7805863L (sv) | 1979-11-24 |
| NL950028I1 (nl) | 1996-03-01 |
| NL950028I2 (nl) | 1997-04-01 |
| JPS557203A (en) | 1980-01-19 |
| FR2426690B2 (enrdf_load_html_response) | 1982-05-28 |
| CH633014A5 (en) | 1982-11-15 |
| NL7806659A (nl) | 1979-12-27 |
| FR2426690A2 (fr) | 1979-12-21 |
| GB1603127A (en) | 1981-11-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4945102A (en) | Heterocyclic derivatives and radiosensitizing agents and antiviral agents comprising same as their active component | |
| DE2433105C2 (enrdf_load_html_response) | ||
| SE441751B (sv) | Forfarande for framstellning av nya rifamyciner | |
| EP0319947A2 (en) | Bis-S-alkylbenzene derivatives | |
| Kazakova et al. | The synthesis and anti-inflammatory activity of quinopimaric acid derivatives | |
| FR2625998A1 (fr) | Procede de preparation d'hydroxyalkyl-1 methyl-2 nitro-5 imidazoles | |
| US3793314A (en) | Cinnamic acid esters of 7-nitro-8-hydroxy-quinoline | |
| DE68907083T2 (de) | Abkoemmlinge von 2-cyclopentenon. | |
| EP0555769A2 (de) | Verfahren zur Herstellung von Cephem-Prodrug-Estern | |
| DE2359773C2 (enrdf_load_html_response) | ||
| CA1173030A (en) | Rifamycin derivatives | |
| EP0139859B1 (de) | 1,4-Dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
| GB2098593A (en) | Isoxazoles | |
| SRIVASTAVA et al. | Synthesis of new 5, 3/5 and 2-substituted (1, 3, 4)-oxadiazoles and their related products as potential antifungal and antiviral agents | |
| DE2704793C2 (de) | 4-Hydroxy-l,2-benzisothiazole | |
| EP0164010B1 (de) | 3-Nitro-dihydropyridine, Verfahren zu ihrer Herstellung sowie ihre Verwendung in Arzneimitteln | |
| KR820000546B1 (ko) | 리파마이신화합물의 제조방법 | |
| US3128312A (en) | Glyoxylylbenzophenone derivatives | |
| DE3780730T2 (de) | Optisch wirksame beta-aminosaeure derivate und ihre salze und verfahren zu deren herstellung. | |
| JP2631668B2 (ja) | 新規ウロカニン酸誘導体 | |
| NL8203768A (nl) | Werkwijze voor de bereiding van vincaminezuuresters. | |
| FI63238B (fi) | Foerfarande foer framstaellning av antibiotiska spiropiperidylrifamyciner | |
| DE2134451B2 (de) | 1,4-Dihydro-1 -methoxy-e^-methylendioxy-4-oxo-3-chinolincarbonsäure und Verfahren zu deren Herstellung | |
| DE2811131A1 (de) | Imino-benzoxazin- und imino-benzothiazin-derivate sowie verfahren zu deren herstellung | |
| DE2119396C3 (de) | Thiazolo eckige Klammer auf 5,4-f eckige Klammer zu chinolinderivate und ein Verfahren zu deren Herstellung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| SPCF | Application for supplementary protection certificate filed |
Free format text: 7805863 |
|
| NAL | Patent in force |
Ref document number: 7805863-3 Format of ref document f/p: F |
|
| SPCG | Supplementary protection certificate granted |
Free format text: 9490133, 931203, EXPIRES: 20030523 |
|
| NUG | Patent has lapsed |
Ref document number: 7805863-3 Format of ref document f/p: F |